OK Biotech Co., Ltd.
TAI: 4155.TW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taiwan Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Jia-De Lai
- Employees
- 62
- Headquarters
- Hsinchu City, Taiwan
- IPO year
- 2012
- Market cap
- NT$1.9B
- Website
- https://www.okbiotech.com
Loading 4155…
Loading profile data…Frequently asked questions about 4155
What does OK Biotech Co., Ltd. (4155.TW) do?
OK Biotech Co., Ltd. manufactures and sells blood glucose meters worldwide. It also provides nebulizers, glucometers, blood sugar meters, blood glucose test strips, and personal sound amplifiers. The company was founded in 2006 and is headquartered in Hsinchu City, Taiwan.
Where does 4155.TW trade?
OK Biotech Co., Ltd. (4155.TW) trades on the Taiwan Stock Exchange.
What sector is 4155.TW in?
OK Biotech Co., Ltd. (4155.TW) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of OK Biotech Co., Ltd.?
Jia-De Lai is the chief executive officer of OK Biotech Co., Ltd. (4155.TW).
Where is OK Biotech Co., Ltd. headquartered?
OK Biotech Co., Ltd. is headquartered in Taiwan.
Does 4155.TW pay a dividend?
Yes — OK Biotech Co., Ltd. (4155.TW) paid a trailing twelve-month dividend of TWD 0.30 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 4155.TW go public?
OK Biotech Co., Ltd. (4155.TW) completed its initial public offering in 2012.